Neuroprotective effects of Echinacoside in cellular and animal models of Parkinson's disease

被引：0
|
作者：
Geng, Xingchao
Tian, Xuefei
Tu, Pengfei
Pu, Xiaoping
机构：
[1] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Dept Nat Med, Beijing, Peoples R China
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
echinacoside; MPTP; 6-OHDA; Parkinson's disease;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] DIFFERENTIAL EXPRESSION OF PROTEINS IN CELLULAR AND ANIMAL MODELS OF PARKINSON'S DISEASE
    Dutta, D.
    Banerjee, E.
    Appukuttan, T. A.
    Hareendran, S.
    Varghese, M.
    Sindhu, K. M.
    Mohanakumar, K. P.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 142 - 142
  • [22] Neuroprotective effects of Korean medicinal plants in animal model of Parkinson's disease
    Han, B. S.
    Kim, K. S.
    Kim, Y. J.
    Jung, H. Y.
    Kang, Y. M.
    Sohn, M. J.
    Kim, W. G.
    PLANTA MEDICA, 2016, 82
  • [23] Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease
    Gillies, GE
    Murray, HE
    Dexter, D
    McArthur, S
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 78 (03) : 513 - 522
  • [24] GIP has neuroprotective effects in Alzheimer and Parkinson's disease models
    Zhang, Zhen Qiang
    Holscher, Christian
    PEPTIDES, 2020, 125
  • [25] Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
    Garcia, C.
    Palomo-Garo, C.
    Garcia-Arencibia, M.
    Ramos, J. A.
    Pertwee, R. G.
    Fernandez-Ruiz, J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (07) : 1495 - 1506
  • [26] Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models
    Hu, Li-Fang
    Lu, Ming
    Tiong, Chi Xin
    Dawe, Gavin S.
    Hu, Gang
    Bian, Jin-Song
    AGING CELL, 2010, 9 (02): : 135 - 146
  • [27] A reactive nitrogen species scavenger is neuroprotective in multiple Parkinson's disease animal models
    Hung, L.
    Roberts, B.
    Wilkins, S.
    George, J.
    Pham, C.
    Lim, S.
    Crouch, P.
    Nurjono, M.
    Gunawan, L.
    Critch, N.
    Sherratt, N.
    Cherny, R.
    Bush, A.
    Masters, C.
    Culvenor, J.
    Cappai, R.
    White, A.
    Donnelly, P.
    Villemagne, V.
    Finkelstein, D.
    Barnham, K.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S115 - S115
  • [28] Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials
    Meissner, W
    Hill, MP
    Tison, F
    Gross, CE
    Bezard, E
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (05) : 249 - 253
  • [29] Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
    Matthews, RT
    Yang, LC
    Jenkins, BG
    Ferrante, RJ
    Rosen, BR
    Kaddurah-Daouk, R
    Beal, MF
    JOURNAL OF NEUROSCIENCE, 1998, 18 (01): : 156 - 163
  • [30] Neurochemical effects of the R form of α-lipoic acid and its neuroprotective mechanism in cellular models of Parkinson's disease
    Zhao, Hong
    Zhao, Xingcheng
    Liu, Lijuan
    Zhang, Hongxu
    Xuan, Mingwen
    Guo, Zhaohui
    Wang, Hongcai
    Liu, Chang
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2017, 87 : 86 - 94
12345